Susquehanna International Group, LLP Agile Therapeutics Inc Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.18 - $15.25 $2,599 - $220,271
14,444 New
14,444 $3,000
Q2 2022

Aug 15, 2022
BUY
$1.09 - $8.24 $20,229 - $152,926
18,559 New
18,559 $22,000

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email